Skip to Main Content

Elevance Health, Inc.

ELV Real Time Price USD
N/A
N/A
N/A
Price Data Unavailable for ELV
Add to Watchlist
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

$ELV is featured in our Sheldon Whitehouse strategy.

See All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ELV by members of U.S. Congress

Politician Type Traded
Michael T. McCaul House / R Sale $15,001 - $50,000 Jun 16, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 May 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 May 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 19, 2025
Robert Bresnahan House / R Sale $15,001 - $50,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Apr 29, 2025
Dan Newhouse House / R Sale $1,001 - $15,000 Apr 11, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Jared Moskowitz House / D Sale $1,001 - $15,000 Mar 10, 2025
Jared Moskowitz House / D Sale $1,001 - $15,000 Mar 10, 2025
Jared Moskowitz House / D Sale $1,001 - $15,000 Mar 10, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Feb 24, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Jan 13, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Jan 09, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 19, 2024
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 19, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Nov 15, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Nov 12, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Nov 08, 2024
Byron Donalds House / R Exchange $1,001 - $15,000 N/A
Michael T. McCaul House / R Sale $50,001 - $100,000 N/A
John James House / R Sale $1,001 - $15,000 Sep 04, 2024
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 26, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Jul 05, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Jul 01, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 May 29, 2024
Ro Khanna House / D Sale $1,001 - $15,000 May 28, 2024
Dan Newhouse House / R Purchase $1,001 - $15,000 Apr 10, 2024
Michael T. McCaul House / R Sale $100,001 - $250,000 Mar 25, 2024
Michael T. McCaul House / R Sale $100,001 - $250,000 Mar 25, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Feb 13, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Feb 01, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Feb 01, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 05, 2023
John R. Curtis House / R Sale $1,001 - $15,000 Dec 04, 2023
John James House / R Purchase $1,001 - $15,000 Nov 16, 2023
John James House / R Purchase $1,001 - $15,000 Nov 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 31, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct 24, 2023
Byron Donalds House / R Exchange $1,001 - $15,000 Oct 19, 2023
Michael T. McCaul House / R Purchase $50,001 - $100,000 Oct 13, 2023
Michael T. McCaul House / R Purchase $50,001 - $100,000 Oct 13, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 10, 2023
Markwayne Mullin Senate / R Purchase $1,001 - $15,000 Oct 03, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 02, 2023
Michael T. McCaul House / R Purchase $50,001 - $100,000 Sep 29, 2023
Michael T. McCaul House / R Purchase $50,001 - $100,000 Sep 29, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep 26, 2023
ELV Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ELV Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ELV Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Whales49.33333333New7Increased42Held27Decreased55Closed17

Quarterly net insider trading by ELV's directors and management

2024Q32024Q42025Q12025Q22025Q3−35k−30k−25k−20k−15k−10k−5k0
Net Shares Purchased by Insiders

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $2,520,000 Apr 21, 2025 Issue: Health Issues Insurance Medicare/Medicaid Pharmacy
  • $1,210,000 Jan 29, 2025 Issue: Health Issues Insurance Medicare/Medicaid Pharmacy
  • $1,220,000 Oct 21, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,330,000 Jul 22, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
  • $2,350,000 Apr 22, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,460,000 Jan 22, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,250,000 Nov 06, 2023 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,430,000 Jul 20, 2023 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,270,000 Jan 20, 2023 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,590,000 Oct 20, 2022 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,570,000 Oct 20, 2022 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
  • $1,570,000 Jul 20, 2022 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
  • $50,000 Apr 20, 2022 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $60,000 Apr 05, 2022 Issue: Health Issues
  • $30,000 Jan 14, 2022 Issue: Health Issues
  • $30,000 Oct 19, 2021 Issue: Health Issues
  • $680,000 Oct 21, 2019 Issue: Pharmacy Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $1,110,000 Jul 22, 2019 Issue: Consumer Issues/Safety/Products Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $730,000 Oct 22, 2018 Issue: Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products
  • $2,400,000 Oct 20, 2016 Issue: Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products
  • $1,050,000 Jul 20, 2016 Issue: Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products
  • $1,370,000 May 05, 2016 Issue: Insurance Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products

Estimated quarterly lobbying spending

2021202220232024202501M2M3M4M5M6M
Q4Q3Q2Q1Lobbying Amount

ELV Revenue by Segment or Geography

By Segment
By Geography
Premiums$40.9BProduct Revenue$5.8BService Fees and Oth...$2.1B
Historical Trends for ELV

As of: Q1 2025 (03/31/2025)

Click on a segment for historical trends.
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ELV Income Statement
ELV Balance Sheet
ELV Cash Flow
U.S. Patents

New patents grants

  • Patent Title: System and method of assessing sentiment of an organization Jan. 28, 2025
  • Patent Title: Automated self service on a multi-cloud network platform Dec. 31, 2024
  • Patent Title: Systems and methods for virtual assistant enhanced access of services related to private information using a voice-enabled device Dec. 31, 2024
  • Patent Title: Systems and methods for automated cloud provisioning Oct. 29, 2024
  • Patent Title: System and method for operational workflow transparency and end-to-end events tracking Sep. 10, 2024
  • Patent Title: Smart help platform Aug. 13, 2024
  • Patent Title: Systems and methods for automated cloud provisioning Jul. 16, 2024
  • Patent Title: Methods for evaluating clinical comparative efficacy using real-world health data and artificial intelligence Jan. 30, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ELV News

Recent insights relating to ELV

New Analyst Forecast: $ELV Given $434.0 Price TargetArticle Thumbnail
New disclosure: Rep. Jefferson Shreve sold $15,001-$50,000 of $ELV on 05/12Article Thumbnail
New Analyst Forecast: $ELV Given $500.0 Price TargetArticle Thumbnail
New disclosure: Rep. Gilbert Cisneros sold $1,001-$15,000 of $ELV on 05/30Article Thumbnail
New disclosure: Rep. Rob Bresnahan sold $15,001-$50,000 of $ELV on 05/15Article Thumbnail
New disclosure: Rep. Dan Newhouse sold $1,001-$15,000 of $ELV on 04/11Article Thumbnail
Fund Update: Empowered Funds, LLC Just Disclosed New HoldingsArticle Thumbnail
UnitedHealth (UNH) Faces DOJ Probe, Shares Dive 16% on Fraud InvestigationArticle Thumbnail
Fund Update: Findlay Park Partners LLP Just Disclosed New HoldingsArticle Thumbnail
Congressmember Sheldon Whitehouse's New Portfolio HoldingsArticle Thumbnail
New disclosure: Rep. Gilbert Cisneros purchased $1,001-$15,000 of $ELV on 04/29Article Thumbnail
Congress Trade: Representative Gilbert Ray Cisneros, Jr. Just Disclosed New Stock TradesArticle Thumbnail
Fund Update: Applied Finance Capital Management, LLC opened a $1.4M position in $ELV stockArticle Thumbnail
New Analyst Forecast: $ELV Given $465.0 Price TargetArticle Thumbnail
New Lobbying Disclosure: ELEVANCE HEALTH ($ELV) disclosed lobbying (Facilitate discussions on PBM reform, ACA tax credits, and Medicaid policy.)Article Thumbnail
Fund Update: Canoe Financial LP Just Disclosed New HoldingsArticle Thumbnail
ELEVANCE HEALTH Earnings Results: $ELV Reports Quarterly EarningsArticle Thumbnail
Lobbying Update: $2,520,000 of ELEVANCE HEALTH INC. lobbying was just disclosedArticle Thumbnail
New Lobbying Disclosure: ELEVANCE HEALTH INC. ($ELV) disclosed spending $2520000 lobbying (ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 740) Veterans Affairs Community Cares program Dept. of Defense Military OneSource Program Provider Directories Transparency in Coverage and Machine-Readable Files Change Healthcare Cyber Incident Telehealth Modernization Act of 2024 Addressing Anti-Competitive Contracting Clauses Act No Suprises Act Implementation Physician Led and Rural Access to Quality Care Act (H.R. 2191) Full-Year Continuing Appropriations and Extensions Act of 2025 (H.R.1968) )Article Thumbnail
New Lobbying Disclosure: ELEVANCE HEALTH INC. ($ELV) disclosed spending $90000 lobbying (Issues related to the Medicare Advantage and Medicaid programs.)Article Thumbnail
New Lobbying Disclosure: ELEVANCE HEALTH INC ($ELV) disclosed spending $60000 lobbying (Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment. )Article Thumbnail
ELEVANCE HEALTH Earnings Preview: Recent $ELV Insider Trading, Hedge Fund Activity, and MoreArticle Thumbnail
New Lobbying Disclosure: ELEVANCE HEALTH INC. ($ELV) disclosed spending $90000 lobbying (Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. )Article Thumbnail
Lobbying Update: $60,000 of ELEVANCE HEALTH INC (F.K.A. ANTHEM INC. & WELLPOINT INC.) lobbying was just disclosedArticle Thumbnail
New Lobbying Disclosure: ELEVANCE HEALTH INC (F.K.A. ANTHEM INC. & WELLPOINT INC.) ($ELV) disclosed spending $60000 lobbying (Federal budget issues )Article Thumbnail
New disclosure: Rep. Jared Moskowitz sold $1,001-$15,000 of $ELV on 03/10Article Thumbnail
New disclosure: Rep. Jared Moskowitz sold $1,001-$15,000 of $ELV on 03/10Article Thumbnail
New disclosure: Rep. Jared Moskowitz sold $1,001-$15,000 of $ELV on 03/10Article Thumbnail
Congress Trade: Representative Jared Moskowitz Just Disclosed New Stock TradesArticle Thumbnail
New Analyst Forecast: $ELV Given 'Outperform' RatingArticle Thumbnail
CNBC Recommendations

Recent picks made for ELV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ELV

ELV Analyst Ratings

ELV Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ELV Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ELV stock a Buy, Sell, or Hold?

  • What is the price target for $ELV stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ELV Top Shareholders
Shareholder
Shares Held
ELV Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ELV stock?

  • Who owns the most shares of $ELV stock?

  • What funds own $ELV stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ELV Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ELV Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Bull Case vs Bear Case data is only available to Quiver Premium subscribers.

Back To Top